Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural genomics in endocrinology.

J W Smit1, J A Romijn

  • 1Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, C4-R, PO Box 9600, 3500 RC Leiden, The Netherlands.

Pharmacogenomics
|November 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-specific inflammation and insulin sensitivity in subjects with obesity.

Diabetes research and clinical practice·2024
Same author

Eye-tracking analyses of physician face gaze patterns in consultations.

Scientific reports·2021
Same author

Eye-tracking glasses in face-to-face interactions: Manual versus automated assessment of areas-of-interest.

Behavior research methods·2021
Same author

Effects of nutritional status on acetaminophen measurement and exposure.

Clinical toxicology (Philadelphia, Pa.)·2018
Same author

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.

Clinical and translational gastroenterology·2018
Same author

Effects of meal composition and meal timing on the expression of genes involved in hepatic drug metabolism in rats.

PloS one·2017
Same journal

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Pharmacogenomics·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
See all related articles

Reverse endocrinology, using genomics and proteomics, identifies new molecular pathways and drug targets for endocrine disorders. This approach enhances understanding and treatment of hormonal diseases by integrating molecular and classical methods.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genomics
  • Proteomics

Background:

  • Endocrine research traditionally progressed from phenotype to molecular pathophysiology.
  • This classical approach has yielded significant successes in understanding endocrine disorders.
  • The advent of genomics and proteomics necessitates new research paradigms.

Purpose of the Study:

  • To introduce and define the concept of reverse endocrinology.
  • To highlight the utility of genomics and proteomics in endocrine research.
  • To identify novel molecular pathways and therapeutic targets in endocrinology.

Main Methods:

  • Application of genomics and proteomics to endocrine research.
  • Integration of high-throughput molecular techniques with classical endocrine studies.

Related Experiment Videos

  • Dissection of molecular pathways underlying endocrine health and disease.

    • Main Results:

    • Identification of the peroxisome-proliferator activated receptor (PPAR) nuclear receptor family as a key target.
    • Unveiling of novel molecular pathways through a reverse approach.
    • Demonstration of the power of integrating molecular and classical methods.

    Conclusions:

    • Reverse endocrinology provides powerful tools for dissecting molecular mechanisms.
    • This integrated approach facilitates the discovery of new drug targets.
    • Combining innovative molecular techniques with traditional methods will advance endocrinology and therapeutics.